###begin article-title 0
###xml 43 47 <span type="species:ncbi:10090">Mice</span>
Muscle-Specific IRS-1 Ser-->Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle
###end article-title 0
###begin p 1
###xml 41 64 41 64 <email xmlns:xlink="http://www.w3.org/1999/xlink">gerald.shulman@yale.edu</email>
Corresponding author: Gerald I. Shulman, gerald.shulman@yale.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-Insulin resistance in skeletal muscle plays a critical role in the pathogenesis of type 2 diabetes, yet the cellular mechanisms responsible for insulin resistance are poorly understood. In this study, we examine the role of serine phosphorylation of insulin receptor substrate (IRS)-1 in mediating fat-induced insulin resistance in skeletal muscle in vivo.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 282 297 <span type="species:ncbi:10090">transgenic mice</span>
RESEARCH DESIGN AND METHODS-To directly assess the role of serine phosphorylation in mediating fat-induced insulin resistance in skeletal muscle, we generated muscle-specific IRS-1 Ser302, Ser307, and Ser612 mutated to alanine (Tg IRS-1 Ser-->Ala) and IRS-1 wild-type (Tg IRS-1 WT) transgenic mice and examined insulin signaling and insulin action in skeletal muscle in vivo.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
RESULTS-Tg IRS-1 Ser-->Ala mice were protected from fat-induced insulin resistance, as reflected by lower plasma glucose concentrations during a glucose tolerance test and increased insulin-stimulated muscle glucose uptake during a hyperinsulinemic-euglycemic clamp. In contrast, Tg IRS-1 WT mice exhibited no improvement in glucose tolerance after high-fat feeding. Furthermore, Tg IRS-1 Ser-->Ala mice displayed a significant increase in insulin-stimulated IRS-1-associated phosphatidylinositol 3-kinase activity and Akt phosphorylation in skeletal muscle in vivo compared with WT control littermates.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-These data demonstrate that serine phosphorylation of IRS-1 plays an important role in mediating fat-induced insulin resistance in skeletal muscle in vivo.
###end p 6
###begin p 7
Published ahead of print at  on 15 July 2008.
###end p 7
###begin p 8
K.M. and S.N. contributed equally to this article.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 681 684 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 689 692 689 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 697 700 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 709 712 709 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">636</sup>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 980 982 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 983 985 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1010 1012 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1013 1015 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 1671 1672 1656 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1673 1674 1658 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1675 1677 1660 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1678 1680 1663 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1952 1955 1937 1940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 1960 1963 1945 1948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 1972 1975 1957 1960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
###xml 2026 2030 <span type="species:ncbi:10090">mice</span>
Insulin resistance in skeletal muscle plays a major role in the pathogenesis of type 2 diabetes, yet the cellular mechanisms responsible for insulin resistance in skeletal muscle are poorly understood (1). Reduced insulin-stimulated glucose transport activity exists with reduced insulin receptor substrate (IRS)-1-associated phosphatidylinositol 3-kinase (PI3-kinase) activity in patients with type 2 diabetes and the offspring of type 2 diabetic parents (2-5). Increased serine phosphorylation of IRS-1 has been suggested to be responsible for this phenomenon (6), and, consistent with this hypothesis, recent studies have demonstrated hyperserine phosphorylation of IRS-1 on Ser302, Ser307, Ser612, and Ser636 in several insulin-resistant rodent models (7-10), as well as in lean insulin-resistant offspring of type 2 diabetic parents (11). Circulating factors that are increased in obese and inflammatory states, such as tumor necrosis factor-alpha, activate Ser/Thr kinases (12,13). Also, recent studies (14-18) have demonstrated a strong relationship between intramyocelullar lipid accumulation and insulin resistance in muscle independent of alterations in circulating adipocytokines. Intramyocellular fatty acid metabolites, such as diacylglycerol, have been postulated to activate a serine kinase cascade leading to increased serine phosphorylation of IRS-1. Furthermore, high-fat diet-induced insulin resistance has been abrogated in rodent models in which certain Ser/Thr kinases (c-Jun N-terminal kinase, inhibitor of nuclear factor kappaB kinase beta subunit, S6 kinase-1, and protein kinase C-theta) were either knocked down or pharmacologically inhibited (8,9,19-21). However, it remains unknown whether increased IRS-1 serine phosphorylation plays a causative role in the pathogenesis of fat-induced insulin resistance in skeletal muscle or whether it is merely an associated phenomenon. To address this question, we generated IRS-1 Ser302, Ser307, and Ser612 to Ala mutant-overexpression (Tg IRS-1 Ser-->Ala) mice using a muscle-specific myosin light-chain-2 promoter and assessed insulin responsiveness in vivo by intraperitoneal glucose tolerance tests and hyperinsulinemic-euglycemic clamp studies.
###end p 10
###begin title 11
RESEARCH DESIGN AND METHODS
###end title 11
###begin title 12
Animals and dietary treatment.
###end title 12
###begin p 13
###xml 81 84 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 89 92 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 101 104 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 239 241 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 296 297 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 299 300 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 860 861 858 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 867 868 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 2061 2066 2055 2060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 2110 2111 2104 2105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 2165 2166 2157 2158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2199 2200 2189 2190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2232 2237 2220 2225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 2256 2261 2244 2249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 2266 2271 2254 2259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 244 248 <span type="species:ncbi:10090">Mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 432 447 <span type="species:ncbi:10090">transgenic mice</span>
###xml 892 907 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 926 932 <span type="species:ncbi:10090">murine</span>
###xml 1198 1202 <span type="species:ncbi:10090">Mice</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
###xml 1316 1325 <span type="species:ncbi:4222">safflower</span>
###xml 1346 1355 <span type="species:ncbi:4222">safflower</span>
###xml 1435 1444 <span type="species:ncbi:4222">safflower</span>
###xml 2042 2057 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2273 2277 <span type="species:ncbi:10090">mice</span>
Tg IRS-1 Ser-->Ala mutants were generated by microinjection of mutated IRS-1 (Ser302, Ser307, and Ser612) complementary DNA constructs ligated to the myosin light-chain-2 promoter directly into fertilized oocytes, as described previously (22). Mice were backcrossed with C57BL/6J mice until the F2-F3 generation and male animals were selected for experiments in this study. All control mice (wild type [WT]) were littermates of the transgenic mice. From 25 positive founders, three lines were selected based on their protein expression of IRS-1 (approximately two times). These three lines showed similar phenotype when analyzed by intraperitoneal glucose tolerance tests (IPGTTs). To reduce the possibility of the mixed background attenuating the phenotype, we backcrossed one line for six generations but observed no metabolic phenotype differences between F2 and F6 backcross populations. Transgenic mice overexpressing WT murine IRS-1 (Tg IRS-1 WT) were generated by the same approach using exactly the same expression vector except for the mutated serine residues. Two lines were selected based on their protein expression of IRS-1 (approximately two times more IRS-1 protein in Tg IRS-1 WT). Mice were singly housed under standard vivarium conditions. At the age of 7-8 weeks, mice were started on a high-fat, safflower oil-based diet (27% safflower oil and 59% fat-derived calories, 5.18 kcal/g) and maintained for 8 weeks. The safflower oil diet (no. 112245; Dyets, Bethlehem, PA) was supplemented with minerals and vitamins (no. 210025 and 310025). Food was exchanged every third day, and individual food consumption rates, body weight gain, and body composition using in vivo nuclear magnetic resonance spectroscopy (Minispec MQ10 analyzer; Bruker Optics, Billerica, MA) were measured at baseline and weekly throughout dietary intervention. After 4 weeks, high-fat diet feeding and IPGTT experiments (1 g glucose/kg body wt) were carried out. To examine Tg IRS-1 Ser-->Ala in a different model, we also generated Tg IRS-1 Ser-->Ala transgenic mice on ob/ob background according to a previous report (9). Briefly, we backcrossed Tg IRS-1 Ser-->Ala with ob/+ and mated Tg IRS-1 Ser-->Ala/ob/+ to generate Tg IRS-1 Ser-->Ala/ob/ob and nontransgenic ob/ob (WT/ob/ob) mice.
###end p 13
###begin p 14
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
For insulin-signaling experiments, mice received a single intraperitoneal injection of 0.6 units/kg insulin and tissues and plasma were harvested 15 min later. All experiments were performed in 16-h food-deprived mice. After an additional 4 weeks of high-fat diet treatment, hyperinsulinemic-euglycemic clamp experiments were performed. One week before clamp experiment, permanent catheters were inserted into the left jugular vein under deep anesthesia (intraperitoneal injection of ketamine/xylazine: 80/10 mg/kg body wt) and mice were allowed to regain preoperative weight for 5-7 days. All procedures were approved by the Yale University Animal Care and Use Committee.
###end p 14
###begin title 15
Euglycemic-hyperinsulinemic glucose clamp experiments.
###end title 15
###begin p 16
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 488 489 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 561 563 559 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 569 571 567 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 946 947 938 939 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 951 953 943 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 967 969 959 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1036 1037 1028 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1051 1052 1043 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1053 1054 1045 1046 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1063 1065 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1198 1199 1190 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Conscious mice were placed in restraining tubes and their tails were secured with tape. In vivo experiments lasted for 240 min and consisted of a 120-min basal period directly followed by a 120-min euglycemic-hyperinsulinemic clamp. Initiating the basal period, a prime-continuous [3-3H]glucose infusion (10 muCi bolus, 0.1 muCi/min) was started and continued throughout the whole experiment, allowing the estimation of postabsorptive basal versus insulin-stimulated glucose turnover. At t = 0 min of the clamp, a primed-continuous insulin infusion (2.5 mU . kg-1 . min-1 Novolin; Novo Nordisc Pharmaceuticals, Princeton, NJ) was started, raising insulin levels within a physiologic range. Euglycemia was maintained by a variable glucose (D-20) infusion. Steady-state conditions for plasma glucose concentration (121 +/- 7 in Tg IRS-1 Ser-->Ala vs. 131 +/- 6 mg/dl in WT) and specific activities were achieved within 70 min, and a single 2-deoxy-d-[1-14C]glucose (2-[14C]DG) injection was administered at 75 min. To determine plasma [3-3H]glucose and 3H2O and 2-[14C]DG concentrations, blood samples were collected at 80, 85, 90, 100, 110, and 120 min of the clamp and, for measurement of basal [3-3H]glucose concentrations, in the final 10 min of the basal period. A plasma sample for determination of basal insulin levels was obtained during the final 10 min of the basal period and for steady-state insulin levels (47 +/- 5 in Tg IRS-1 Ser-->Ala vs. 44 +/- 5muU/ml in WT) at 120 min of the clamp. Infusions were performed using microdialysis pumps (CMA/Microdialysis, North Chelmsford, MA), and radioisotopes were purchased from Perkin Elmer Life Sciences (Boston, MA) and American Radiolabeled Chemicals (St. Louis, MO). At the end of the experiment, animals were anesthetized with intravenous ketamine/xylazine (80/10 mg/kg body wt), and epididymal white adipose tissue and M. gastrocnemius, including M. soleus, M. quadriceps, and liver, were collected, freeze-clamped, and stored at -80degreesC until further analysis.
###end p 16
###begin title 17
Calculations.
###end title 17
###begin p 18
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 295 297 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 305 307 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 341 342 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 441 442 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 442 443 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 444 445 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 445 446 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 534 535 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 536 537 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 610 612 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 673 675 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 751 753 750 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 878 879 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 880 882 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 883 885 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
Steady-state period (when the rate of glucose appearance [Ra] equals the rate of glucose disappearance [Rd]) was defined as the final 20-30 min of the glucose clamp. The Ra was calculated as the ratio of [3-3H]glucose infusion rate (dpm/min) and plasma [3-3H]glucose-specific activity (dpm . min-1 . mumol-1) during steady state. Hepatic [3-3H]glucose production was determined by subtracting the steady-state glucose infusion rate from the Ra/Rd. Whole-body glycolysis was determined by linear regression from the increase of plasma 3H2O from 80 to 120 min (measured at 80, 85, 90, 100, 110, and 120 min). 2-[14C]DG uptake in skeletal muscle was calculated from plasma 2-[14C]DG area under the curve at 80, 85, 90, 100, 110, to 120 min and tissue 2-[14C]DG-6-phosphate content using ion-exchange columns (Poly-Prep no. 731-6211; Bio-Rad, Hercules, CA) as previously described (4,23,24).
###end p 18
###begin title 19
Assays from plasma.
###end title 19
###begin p 20
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 268 270 268 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 282 283 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 388 389 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 439 440 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 446 448 446 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 152 157 <span type="species:ncbi:4182">Kobas</span>
Glucose concentrations were determined with a glucose analyzer (Beckman, Fullerton, CA), and triacylglycerol and nonesterified fatty acid levels with a Kobas Mira Analyzer (Roche Diagnostics). Plasma insulin was measured via radioimmunoassay. Plasma [3-3H]glucose, 2-[14C]DG, and 3H2O radioactivity were determined from deproteinized plasma samples (somogyi filtrates) before and after 3H2O was completely evaporated from the supernatant. 3H and 14C radioactivity were assessed by use of a liquid scintillation counter (Ultima Gold; Packard Instrument, Meriden, CT).
###end p 20
###begin title 21
Intramuscular triacylglycerol content.
###end title 21
###begin p 22
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
The extraction procedure for tissue triacylglycerol was adapted from methods described previously (25,26). Triacylglycerol content of each sample was measured in duplicate after evaporation of the organic solvent using an enzymatic method (Sigma Diagnostics, St. Louis, MO).
###end p 22
###begin title 23
Insulin signaling.
###end title 23
###begin p 24
###xml 306 308 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1372 1374 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1433 1435 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1593 1596 1579 1582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">473</sup>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 1982 1986 <span type="species:ncbi:9925">goat</span>
To assess insulin-signaling molecules, Tg IRS-1 Ser-->Ala, Tg IRS-1 WT, and WT mice were treated with 4 weeks of high-fat diet and gastrocnemius muscle was harvested 15 min after intraperitoneal insulin injection (0.6 units/kg). Western blot and immunoprecipitation were performed as described previously (27). Briefly, samples were homogenized in a buffer containing 50 mmol/l Hepes (pH 7.4), 150 mmol/l NaCl, 1 mmol/l EDTA, 1% Triton X-100, 2 mmol/l sodium vanadate, 100 mmol/l NaF, 20 mmol/l sodium pyrophosphate, 20 mg/ml of aprotinin, and 1 mmol/l phenylmethylsulphonyl fluoride. One milligram of lysate was subjected to immunoprecipitation and incubated with 4 mg of anti-IRS-1 or -IRS-2 antibody (Upstate Biotechnology) for 2 h at 4degreesC and then with protein A/G agarose (Santa Cruz) overnight. The beads were washed three times before immunoblot analysis. Samples were denatured with Laemmli sample buffer for 5 min at 95degreesC, and the supernatant was separated using 10% SDS gel (Bio-Rad Laboratories) and electrotransferred onto polyvinylidene fluoride membranes (Amersham Pharmacia Biotech). Samples were probed with anti-phosphotyrosine (4G10-HRP; Upstate Biotechnology) and anti-p85 antibody (Upstate Biotechnology). IRS-1-and IRS-2-associated PI3-kinase assays were performed in 4 mg muscle protein extracts according to methods previously described (28). Western blotting was performed as described previously (27). Forty micrograms of homogenized samples were blotted on polyvinylidene fluoride membranes. The membrane was probed with antibodies against phospho-Akt (Ser473) (1:1,000; Cell Signaling), IRS-1 (1:1,000; Upstate Biotechnology), IRS-1pSer307 (1:1,000; Cell Signaling), and IRS-1pSer612 (1:1,000; Cell Signaling) overnight at 4degreesC. Antibodies against IRS-1pSer307 and IRS-1pSer612 were diluted in the enhancer solution (Can Get Signal Solution; Toyobo, Osaka, Japan). Equal protein loading was confirmed by reblotting of the membranes with a goat polyclonal antibody to pan-actin (1:1,000; Santa Cruz Biotechnology) or anti-Akt antibody (1:1,000; Cell Signaling). Images were analyzed and quantified with Quantity One (Bio-Rad Laboratories).
###end p 24
###begin title 25
Statistical analysis.
###end title 25
###begin p 26
###xml 61 62 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 105 106 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
All data are expressed as means +/- SE. Two-tailed Student's t tests were performed on data at a minimum P < 0.05 threshold.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
High-fat diet increased serine phosphorylation of IRS-1.
###end title 28
###begin p 29
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 274 281 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
To evaluate previous reports regarding increased serine phosphorylation on IRS-1 in skeletal muscle, we tested Ser307 and Ser612 residues using high-fat-fed mice and ob/ob mice. We found slight increases on Ser307 and Ser612 but decreased total IRS-1 protein in ob/ob mice (Fig. 1A).
###end p 29
###begin title 30
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Generation of IRS-1 Ser-->Ala mutant transgenic and Tg IRS-1 WT mice.
###end title 30
###begin p 31
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 293 300 293 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 537 538 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 543 544 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 531 544 519 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic> and <italic>D</italic></xref>
###xml 838 839 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 832 839 816 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1014 1015 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1020 1021 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1008 1021 992 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic> and <italic>D</italic></xref>
###xml 142 157 <span type="species:ncbi:10090">transgenic mice</span>
###xml 479 494 <span type="species:ncbi:10090">transgenic mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
To investigate the role of serine phosphorylation on IRS-1 in mediating fat-induced insulin resistance, we generated skeletal muscle-specific transgenic mice with triple mutations in Ser302, Ser307, and Ser612 to Ala using the 1.2-kb enhancer/promoter region of the myosin light-chain-2 gene (Fig. 1B). Total IRS-1 protein expression levels were analyzed in multiple insulin target organs. We observed approximately100% overexpression of IRS-1 exclusively in skeletal muscles in transgenic mice compared with their WT littermates (Fig. 1C and D). To address whether the phenotype of Tg IRS-1 Ser-->Ala protection against fat-induced insulin resistance depended on the Ser-->Ala mutation of IRS-1, and not on the overexpression of IRS-1 per se, we also generated mice overexpressing WT IRS-1 (Tg IRS-1 WT) as an alternative control (Fig. 1B). Using the same approach, we created a line of Tg IRS-1 WT mice that expressed IRS-1 WT protein in skeletal muscle approximately twofold more than the WT littermates (Fig. 1C and D).
###end p 31
###begin title 32
Metabolic phenotype in standard diet-fed Tg IRS-1 Ser-->Ala and their littermates.
###end title 32
###begin p 33
###xml 104 105 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 98 105 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 182 189 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 319 320 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 313 320 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 371 372 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 576 577 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 589 590 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1122 1123 1102 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1116 1123 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1482 1489 1458 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1601 1608 1577 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1763 1764 1737 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1757 1764 1731 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1830 1831 1804 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1824 1831 1798 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 927 936 <span type="species:ncbi:4222">safflower</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1476 1480 <span type="species:ncbi:10090">mice</span>
###xml 1703 1707 <span type="species:ncbi:10090">mice</span>
###xml 1872 1876 <span type="species:ncbi:10090">mice</span>
Growth curves of Tg IRS-1 Ser-->Ala and WT mice were comparable between standard diet-fed groups (Fig. 2A). Tg IRS-1 Ser-->Ala mice displayed no differences in any basal parameters (Table 1) and had similar plasma glucose responses following an intraperitoneal glucose challenge when fed a control standard diet (Fig. 2B). The body composition of these mice, analyzed by 1H-nuclear magnetic resonance spectroscopy, were similar in both genotypes (77.0 +/- 0.6% of muscle and 8.5 +/- 0.6% of fat in WT vs. 75.8 +/- 1.0% of muscle and 9.4 +/- 1.3% of fat in Tg IRS-1 Ser-->Ala; P = 0.28 and P = 0.50, respectively). Overexpression of mutated IRS-1, but not WT IRS-1, rescued high-fat diet-induced glucose intolerance. To determine whether the Ser-->Ala mutation of IRS-1 would protect mice from fat-induced insulin resistance in skeletal muscle, we fed WT, Tg IRS-1 Ser-->Ala, and Tg IRS-1 WT mice a high-fat diet containing 27% safflower oil for 4 weeks. Tg IRS-1 Ser-->Ala and WT mice increased their whole-body fat content in a comparable fashion (data not shown) but gained slightly more body weight than WT mice (Fig. 2A). Tg IRS-1 WT gained similar body weight after 4 weeks of high-fat regimen (30 +/- 0.5 g at age 12 weeks). There were no differences in fasting plasma glucose, cholesterol, triacylglycerol, and nonesterified fatty acid concentrations among the three groups, yet plasma insulin concentrations were 23% lower in the Tg IRS-1 Ser-->Ala mutant than the WT mice (Table 1). Intramuscular triacylglycerol content after high-fat feeding showed no difference between the two genotypes (Table 1). When IPGTT experiments were performed after 4 weeks of high-fat feeding, Tg IRS-1 Ser-->Ala mice displayed a markedly improved glucose tolerance (Fig. 2B), despite no differences in plasma insulin concentrations (Fig. 2C), compared with both WT and Tg IRS-1 WT mice fed a similar high-fat diet.
###end p 33
###begin title 34
Overexpression of mutated IRS-1 rescued high-fat diet induced insulin resistance in skeletal muscle.
###end title 34
###begin p 35
###xml 432 433 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 426 433 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 549 550 543 544 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 631 633 623 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 639 641 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 669 671 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 677 679 667 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 681 682 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 742 744 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 750 752 738 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 782 784 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 790 792 776 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 794 795 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 811 812 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 805 812 791 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1007 1009 987 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1015 1017 995 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1073 1075 1049 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1081 1083 1057 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1085 1086 1061 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
To determine which tissue was responsible for the enhanced glucose tolerance in the Tg IRS-1 Ser-->Ala mice, we performed hyperinsulinemic-euglycemic clamp experiments in age-matched WT and Tg IRS-1Ser-->Ala mice after 8 weeks of high-fat diet treatment. Tg IRS-1 Ser-->Ala mice manifested greater insulin sensitivity, as reflected by a 34% increased in glucose infusion rate required to maintain euglycemia during the clamp (Fig. 3A). Further analysis of plasma and skeletal muscle tracer data revealed a 50% increase in insulin-stimulated 2-deoxy-d-[1-14C]glucose uptake in both the gastrocnemius muscles (274.2 +/- 39.9 nmol . g-1 . min-1 vs. 414.9 +/- 46.3 nmol . g-1 . min-1; P < 0.05) and the quadriceps muscles (287.6 +/- 48.3 nmol . g-1 . min-1 vs. 0.518.9 +/- 98.1 nmol . g-1 . min-1; P < 0.05) (Fig. 3B). In contrast, there were no differences in insulin-mediated suppression of hepatic glucose production between the Tg IRS-1 Ser-->Ala and the WT mice (basal 16.6 +/- 1.0 vs. 17.6 +/- 1.2 mg . kg-1 . min-1, insulin-stimulated 5.0 +/- 3.7 vs. 0.1 +/- 2.8 mg . kg-1 . min-1; P = 0.27).
###end p 35
###begin title 36
Ser-->Ala mutation on IRS-1, but not overexpression of IRS-1, improved insulin signaling.
###end title 36
###begin p 37
###xml 475 476 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 469 476 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 617 618 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 611 618 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 700 701 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 694 701 690 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 958 959 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 952 959 944 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E</italic></xref>
###xml 961 965 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 1065 1066 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1059 1066 1049 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E</italic></xref>
###xml 1068 1073 1058 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
To further analyze the mechanism for the improved insulin-stimulated muscle glucose uptake in the Tg IRS-1 Ser-->Ala mice, we assessed insulin signaling in vivo after 4 weeks of high-fat diet treatment. High-fat feeding reduced insulin-stimulated Akt phosphorylation in gastrocnemius muscle after 15 min of intraperitoneal insulin injection in WT mice; however, we observed a 32% increase in Akt phosphorylation in Tg IRS-1 Ser-->Ala mice compared with WT littermates (Fig. 3C). We also analyzed insulin-induced Akt phosphorylation in Tg IRS-1 WT, but we did not observe significant improvement in Tg IRS-1 WT (Fig. 3C). We also detected a 20% increase in IRS-1-associated PI3-kinase activity (Fig. 3D) of Tg IRS-1 Ser-->Ala compared with WT mice in absence of changes in IRS-2-associated PI3-kinase activity (data not shown). Furthermore, tyrosine phosphorylation of IRS-1 was increased by 88% in Tg IRS-1 Ser-->Ala mice compared with WT littermates (Fig. 3E, left). IRS-1-associated p85 subunit of PI3-kinase was also 83% higher in Tg IRS-1 Ser-->Ala mice (Fig. 3E, right).
###end p 37
###begin title 38
###xml 113 118 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Overexpression of mutated IRS-1 improved glucose metabolism in old mice and Tg IRS-1 Ser-->Ala mice bred onto an ob/ob background.
###end title 38
###begin p 39
###xml 318 319 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 324 325 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 312 325 310 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic> and <italic>B</italic></xref>
###xml 499 504 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 596 601 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 623 628 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 673 674 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 742 747 724 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 755 760 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 784 785 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 778 785 760 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 823 828 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 897 902 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
To analyze the effect of overexpression of mutated IRS-1 in different insulin resistance models, we tested these mice at age 1 year with an IPGTT. Tg IRS-1 Ser-->Ala mice showed better glucose tolerance compared with their littermates at age 1 year, although they had similar insulin concentration during IPGTT (Fig. 4A and B) and similar body weight (Tg IRS-1 Ser-->Ala 48.1 +/- 0.7 vs. WT 48.5 +/- 0.3). In addition, we also examined the effect of backcrossing the Tg IRS-1 Ser-->Ala mice onto an ob/ob background and found lower fasting plasma glucose concentrations in the Tg IRS-1 Ser-->Ala/ob/ob compared with the WT/ob/ob mice (306 +/- 23 mg/dl vs. 218 +/- 9 mg/dl; P = 0.005) at age 4 weeks. Although growth curves of IRS-1 Ser-->Ala/ob/ob and WT/ob/ob were comparable (Fig. 4C), fasting glucose of IRS-1 Ser-->Ala/ob/ob tended to be lower throughout their life until age 16 weeks than WT/ob/ob mice (data not shown).
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 273 276 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 285 288 285 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 617 620 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 637 640 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">318</sup>
###xml 716 719 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 727 730 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 976 979 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 984 987 984 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">632</sup>
###xml 992 995 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">662</sup>
###xml 1004 1007 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">731</sup>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1183 1186 1183 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 1330 1332 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 1622 1623 1620 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1616 1623 1614 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1975 1978 1971 1974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 1984 1987 1978 1981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 1998 2000 1992 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 2001 2003 1995 1997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 2301 2302 2295 2296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2295 2302 2289 2296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 2496 2498 2490 2492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 2585 2590 2579 2584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 2625 2626 2619 2620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2619 2626 2613 2620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 2690 2695 2684 2689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 2750 2752 2744 2746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 1610 1614 <span type="species:ncbi:10090">mice</span>
###xml 1796 1800 <span type="species:ncbi:10090">mice</span>
###xml 2359 2365 <span type="species:ncbi:9606">humans</span>
###xml 2591 2595 <span type="species:ncbi:10090">mice</span>
###xml 2613 2617 <span type="species:ncbi:10090">mice</span>
Our study demonstrates that serine phosphorylation on IRS-1 is a key molecular event in the pathogenesis of fat-induced insulin resistance in vivo. Although IRS-1 has >70 potential serine/threonine phosphorylation sites, we observed that mutating the serines at Ser302, Ser307, and Ser612 to alanines partially, but significantly, protected the mice against fat-induced insulin resistance in skeletal muscle. Previous in vitro studies speculated four possible mechanisms by which serine phosphorylation of IRS-1 can inhibit the insulin-signaling pathway. First, it has been reported that serine phosphorylation on Ser302, Ser307, and Ser318 inhibits the association between the insulin receptor and IRS-1 because Ser302 and Ser307 exist near the phosphotyrosine binding domain (155-259), where the insulin receptor binds to IRS-1 (29-31). Second, serine phosphorylation has been shown to interfere with the tyrosine phosphorylation of IRS-1 (32). Third, phosphorylation on Ser612, Ser632, Ser662, and Ser731 has been demonstrated to inhibit the association between IRS-1 and the p85 subunit of PI3-kinase (31,33). Finally, serine phosphorylation or IRS-1 on certain sites such as Ser307 has been shown to promote protein degradation through the ubiquitin-proteosome pathway and/or the suppressor of cytokine-signaling pathway (34-36). The data in the present study support the hypothesis that in vivo IRS-1 serine phosphorylation intereferes with IRS-1 tyrosine phosphorylation by the first three mechanisms, since we found increased insulin-stimulated IRS-1 tyrosine phosphorylation in the Tg IRS-1 Ser-->Ala mice (Fig. 3D), suggesting at least one of three serine residues regulate interaction between insulin receptor and IRS-1 and/or tyrosine phosphorylation. Furthermore, Tg IRS-1 Ser-->Ala mice also showed an increased association between IRS-1 and the p85 subunit of PI3-kinase, which reflects increased interaction between IRS-1 and PI 3-kinase likely due to the Ser612-->Ala612 mutation (33,37). On the other hand, our data suggest that IRS-1 serine phosphorylation does not lead to increased IRS-1 degradation by activation of the ubiquitin-proteosome or suppressor of cytokine-signaling pathway, since IRS-1 protein expression was unchanged after 8 weeks of high-fat diet treatment (Fig. 1A). These data are also consistent with recent studies in humans demonstrating unaltered IRS-1 expression in the muscle of young lean insulin-resistant offspring of parents with type 2 diabetes (11). In contrast to these results, we did observed decreased IRS-1 protein expression in ob/ob mice compared with WT mice (Fig. 1A), suggesting that increased IRS-1 degradation may occur in the ob/ob phenotype, which is consistent with a previous study (38).
###end p 41
###begin p 42
###xml 795 797 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
To address whether the IRS-1 Ser-->Ala mutation protection from fat-induced insulin resistance depended on the Ser-->Ala mutation of IRS-1 and not on the overexpression of IRS-1 per se, we also generated mice with a similar twofold overexpression of WT IRS-1 (Tg IRS-1 WT) in skeletal muscle as an alternative control. In contrast to the Tg IRS-1 Ser-->Ala mice, Tg IRS-1 WT mice were not protected from high-fat-induced glucose intolerance during IPGTT. Furthermore, in contrast to Tg IRS-1 Ser-->Ala mice, Tg IRS-1 WT mice were also not protected from fat-induced defects in insulin stimulation of Akt phosphorylation in skeletal muscle. These findings are consistent with a recent study demonstrating that whole-body IRS-1 overexpressing mice were also not protected from insulin resistance (39). Taken together, these data support the hypothesis that the protection from fat-induced insulin resistance observed in the Tg IRS-1 Ser-->Ala mice is due to the Ser-->Ala IRS mutation and not due to IRS-1 WT overexpression.
###end p 42
###begin p 43
In summary, our study supports the hypothesis that high-fat diet-induced insulin resistance in skeletal muscle is mediated at least in part through increased serine phosphorylation of IRS-1. This event may be a potential pharmacological target in the treatment of insulin resistance associated with obesity and type 2 diabetes.
###end p 43
###begin p 44
This work was supported by grants from the U.S. Public Health Service (R01 DK-40936, U24 DK-76169, and P30 DK-45735), the Uehara Memorial Foundation (to K.M.), and a Distinguished Clinical Scientist Award from the American Diabetes Association (to G.I.S.). G.I.G. is an investigator of the Howard Hughes Medical Institute.
###end p 44
###begin p 45
###xml 92 97 <span type="species:ncbi:57788">Cline</span>
We thank Aida Grossmann, Rebecca Pongratz, Yanna Kosover, Jorg Rossbacher, Mario Kahn, Gary Cline, Patricia Donovan, and Tom Nuzzo for excellent technical assistance.
###end p 45
###begin title 46
REFERENCES
###end title 46
###begin p 47
###xml 39 40 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 284 285 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 334 337 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 342 345 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">307</sup>
###xml 354 357 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">612</sup>
###xml 431 432 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 584 585 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 738 760 732 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Musculus gastrocnemius</italic>
###xml 766 784 760 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Musclus quadriceps</italic>
###xml 790 816 784 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Musculus tibialis anterior</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
Generation of Tg IRS-1 Ser-->Ala mice. A: Serine phosphorylation of IRS-1 protein in skeletal muscle. Serine phosphorylation of IRS-1 and protein expression of IRS-1 were analyzed by Western blotting. All mice were killed at age 16 weeks. The high-fat diet group was fed for 8 weeks. B: Vector construct of the mutated IRS-1 gene (Ser302, Ser307, and Ser612 to Ala mutant) for Tg IRS-1 Ser-->Ala and WT IRS-1 gene for Tg IRS-1 WT. C: Comparison of IRS-1 expression in different insulin-targeting tissues. Protein expression of total IRS-1 and actin were analyzed by Western blotting. D: Comparison of IRS-1 expression between Tg IRS-1 Ser-->Ala and Tg IRS-1 WT mice. Each graph was expressed as fold difference to their littermates. GAS, Musculus gastrocnemius; QD, Musclus quadriceps; TA, Musculus tibialis anterior; WAT, white adipose tissue.
###end p 47
###begin p 48
###xml 122 123 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 379 379 377 377 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 466 466 462 462 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 557 558 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 706 706 698 698 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 897 897 881 881 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 922 923 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1029 1030 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1057 1058 1037 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1078 1079 1058 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1087 1088 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 280 289 <span type="species:ncbi:4222">safflower</span>
###xml 310 319 <span type="species:ncbi:4222">safflower</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
Tg IRS-1 Ser-->Ala, but not Tg IRS-1 WT, mice were protected from high-fat diet-induced glucose intolerance during IPGTT. A: Growth curves. Body weights were measured weekly under control diet and high-fat diet feeding regimens. At age 7-8 weeks, mice were started on a high-fat, safflower oil-based diet (27% safflower oil, 59% fat-derived calories) and maintained for 8 weeks.  with solid line, WT control diet; * with solid line, Tg IRS-1 Ser-->Ala control diet;  with dotted line, WT high-fat diet; * with dotted line, Tg IRS-1 Ser-->Ala high-fat diet. B: IPGTT. A total of 1 g/kg of 10% glucose was injected in control diet-fed Tg IRS-1 Ser-->Ala mice (* with solid line) and littermate control mice ( with solid line). A total of 1 g/kg of 10% glucose was also injected in high-fat-fed Tg IRS-1 Ser-->Ala (* with dotted line), Tg IRS-1 WT (diamond with dotted line), and littermate control ( with dotted line) mice. C: Area under the curve of insulin concentration during IPGTTs. Results are expressed as means +/- SE (WT, n = 11; Tg IRS-1 Ser-->Ala, n = 16; Tg IRS-1 WT, n = 8). *P < 0.05 vs. WT high-fat diet.
###end p 48
###begin p 49
###xml 93 94 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 255 257 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 263 265 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 483 484 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 548 550 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 572 594 566 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Musculus gastrocnemius</italic>
###xml 602 606 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 612 630 606 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Musclus quadriceps</italic>
###xml 637 642 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 688 689 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 716 717 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 725 726 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 771 774 761 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">473</sup>
###xml 889 890 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 928 929 918 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 956 957 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 977 978 965 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 985 986 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1058 1059 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1086 1087 1072 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1094 1095 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1129 1133 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 1183 1188 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
Tg IRS-1 Ser-->Ala mice were protected from high-fat diet-induced muscle insulin resistance. A: After 8 weeks of high-fat feeding (16 +/- 1 weeks), age-matched mice were food deprived for 16 h and hyperinsulinemic-euglycemic clamp experiments (2.5 mU . kg-1 . min-1) were performed using Tg IRS-1 Ser-->Ala mice and their littermates. Plasma glucose concentration was maintained by an intravenous 20% glucose infusion and glucose infusion rates (GINF) at steady state were assessed. B: Muscle-specific glucose uptake was analyzed by enrichment of [14C]-2-deoxy-glucose in Musculus gastrocnemius (GAS) (left) and Musclus quadriceps (QD) (right). Results are expressed as means +/- SE (WT, n = 12; Tg IRS-1 Ser-->Ala, n = 16). C: Insulin-stimulated Akt phosphorylation (Ser473) in GAS was analyzed 15 min after intraperitoneal injection of 0.6 units/kg insulin in control diet-fed mice (WT, n = 6) and high-fat diet-fed mice (WT, n = 16; Tg IRS-1 Ser-->Ala, n = 15; Tg IRS-1 WT, n = 3). D: IRS-1-associated PI3-kinase activity in GAS of high-fat-fed mice (WT, n = 12; Tg IRS-1 Ser-->Ala, n = 8). E: IRS-1 tyrosine phosphorylation (left) and IRS-1-associated p85 subunit of PI3-kinase (right) were analyzed 15 min after intraperitoneal injection of 0.6 units/kg insulin by immunoprecipitation. Results are expressed as means relative to insulin-stimulated samples of WT high-fat fed mice +/- SE.
###end p 49
###begin p 50
###xml 93 94 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 109 110 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 227 228 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 255 256 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 263 264 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 266 266 260 260 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 351 352 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 387 392 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 523 528 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 530 530 512 512 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 569 572 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 601 604 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 606 606 586 586 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cjs2108.jpg"/>
###xml 625 626 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 636 637 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
Tg IRS-1 Ser-->Ala mice were protected from age-related glucose intolerance. Plasma glucose (A) and insulin (B) concentrations in 1-year-old Tg IRS-1 Ser-->Ala transgenic and WT littermate mice following an IPGTT (1 g/kg) (WT, n = 12; Tg IRS-1 Ser-->Ala, n = 6). A:  WT elder; diamond, Tg IRS-1 Ser-->Ala elder. Results are expressed as means +/- SE. C: Generation of Tg IRS-1 Ser-->Ala/ob/ob. Growth curves: body weights were measured weekly under control diet until age 16 weeks (* with dotted line) and compared with WT/ob/ob ( with dotted line), Tg IRS-1 Ser-->Ala/+/+ (* with solid line), and WT/+/+ ( with solid line); n = 7-10. *P < 0.05 vs. WT littermate mice.
###end p 50
###begin p 51
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 102 111 <span type="species:ncbi:4222">safflower</span>
Plasma metabolites and hormones in Tg IRS-1 Ser-->Ala, Tg IRS-1 WT, and littermate control mice fed a safflower oil diet or a control diet for 4 weeks
###end p 51
###begin p 52
Data are means +/- SE.
###end p 52
###begin p 53
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. WT control diet.
###end p 53
###begin p 54
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 vs. WT high-fat diet.
###end p 54

